You are searching for: hsa04926

---

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T16117 Target Info	Target Name	Nitric-oxide synthase brain (NOS1)
	Target type	Clinical trial Target
	Disease	Headache; Migraine;
	Drugs	NXN-462	Drug Info

T06046 Target Info	Target Name	Nitric-oxide synthase endothelial (NOS3)
	Target type	Clinical trial Target
	Disease	Myocardial infarction; Angina pectoris;
	Drugs	Tilarginine acetate	Drug Info

T02703 Target Info	Target Name	Nitric-oxide synthase inducible (NOS2)
	Target type	Clinical trial Target
	Disease	Osteoarthritis; Endotoxic shock;
	Drugs	MPL-S	Drug Info

T71266 Target Info	Target Name	RAC-gamma serine/threonine-protein kinase (AKT3)
	Target type	Successful Target
	Disease	Breast cancer; Triple negative breast cancer;
	Drugs	Capivasertib	Drug Info

T65864 Target Info	Target Name	Stress-activated protein kinase 2a (p38 alpha)
	Target type	Clinical trial Target
	Disease	Xerophthalmia; Acute coronary syndrome;
	Drugs	Ozagrel	Drug Info

T55729 Target Info	Target Name	Stress-activated protein kinase 2b (p38 beta)
	Target type	Clinical trial Target
	Disease	Alzheimer disease; Rheumatoid arthritis;
	Drugs	VX-745	Drug Info

T40097 Target Info	Target Name	Stress-activated protein kinase JNK1 (JNK1)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer; T-cell leukaemia;
	Drugs	NKP-1339	Drug Info

T53389 Target Info	Target Name	TGF-beta receptor type I (TGFBR1)
	Target type	Clinical trial Target
	Disease	Arteriosclerosis; Non-small-cell lung cancer;
	Drugs	LY2157299	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.